NP
AMGN icon

NorthRock Partners’s Amgen AMGN Stock Holding History

NorthRock Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Sell
6,203
-340
-5% -$116K 0.03% 207
2026
Q1 		$2.3M Buy
6,543
+3,615
+123% +$1.29M 0.04% 194
2025
Q4 		$959K Sell
2,928
-5,426
-65% -$1.72M 0.02% 283
2025
Q3 		$2.36M Sell
8,354
-2,984
-26% -$865K 0.04% 195
2025
Q2 		$3.17M Buy
11,338
+267
+2% +$75.6K 0.08% 96
2025
Q1 		$3.45M Buy
11,071
+780
+8% +$230K 0.12% 81
2024
Q4 		$2.68M Sell
10,291
-954
-8% -$283K 0.09% 98
2024
Q3 		$3.62M Buy
11,245
+573
+5% +$187K 0.12% 84
2024
Q2 		$3.33M Buy
10,672
+173
+2% +$50.8K 0.13% 81
2024
Q1 		$2.99M Buy
10,499
+79
+0.8% +$23.1K 0.11% 94
2023
Q4 		$3M Buy
10,420
+6,556
+170% +$1.79M 0.13% 86
2023
Q3 		$1.04M Buy
3,864
+1,864
+93% +$465K 0.11% 95
2023
Q2 		$444K Sell
2,000
-493
-20% -$114K 0.05% 154
2023
Q1 		$603K Sell
2,493
-330
-12% -$81K 0.06% 130
2022
Q4 		$741K Buy
2,823
+142
+5% +$38.1K 0.08% 115
2022
Q3 		$604K Sell
2,681
-1,541
-36% -$374K 0.07% 125
2022
Q2 		$1.03M Buy
4,222
+1,536
+57% +$376K 0.11% 90
2022
Q1 		$650K Buy
2,686
+1,057
+65% +$243K 0.06% 145
2021
Q4 		$367K Buy
1,629
+176
+12% +$37.1K 0.03% 207
2021
Q3 		$309K Buy
1,453
+347
+31% +$79.9K 0.03% 210
2021
Q2 		$270K Buy
+1,106
New +$272K 0.02% 206
2020
Q4 		– Sell
-932
Closed -$237K – 234
2020
Q3 		$237K Buy
932
+80
+9% +$19.8K 0.03% 190
2020
Q2 		$201K Sell
852
-671
-44% -$153K 0.02% 198
2020
Q1 		$309K Sell
1,523
-1,041
-41% -$227K 0.04% 137
2019
Q4 		$618K Buy
2,564
+1,150
+81% +$253K 0.07% 133
2019
Q3 		$274K Buy
+1,414
New +$271K 0.04% 178

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NorthRock Partners's AMGN Position: Q2 2026 in Review

NorthRock Partners reduced its Amgen (AMGN) stake by 5.2% in Q2 2026, selling an estimated $116K and leaving 6,203 shares worth $2.25M. The position accounts for 0.03% of the portfolio, ranked #207.

NorthRock Partners first reported a position in AMGN in Q3 2019 and has held it in 26 quarters since. The position peaked at $3.62M in Q3 2024. 3,157 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • NorthRock Partners held 6,203 shares of Amgen worth $2.25M as of Q2 2026.
  • NorthRock Partners sold 340 Amgen shares in Q2 2026, an estimated $116K.
  • Amgen made up 0.03% of NorthRock Partners's portfolio in Q2 2026, its #207 holding.
  • NorthRock Partners first reported a position in Amgen in Q3 2019 and has held it in 26 quarters since.
  • NorthRock Partners's Amgen position peaked at $3.62M in Q3 2024.
  • 3,157 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.